NCT00104845已完成1 期
Injection of AJCC Stage IIB, IIC, III, and IV Melanoma Patients With Human and Mouse gp100 DNA: A Phase I Trial to Assess Safety and Immune Response
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 19
- 试验地点
- 1
- 主要终点
- safety and feasibility
研究概览
简要总结
RATIONALE: Vaccines made from DNA may make the body build an effective immune response to kill tumor cells.
PURPOSE: This randomized phase I trial is studying the side effects and best dose of vaccine therapy in treating patients with stage IIB, stage IIC, stage III, or stage IV melanoma.
详细描述
OBJECTIVES:
Primary
- Determine the safety and feasibility of vaccination with human and mouse gp100 DNA in patients with stage IIB, IIC, III, or IV melanoma.
- Determine the maximum tolerated dose of this regimen in these patients.
- Compare the antibody and T-cell response in patients treated with two different vaccination schedules.
Secondary
- Assess antitumor response in patients treated with this regimen.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Crossover
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
结局指标
主要结局
safety and feasibility
时间窗: 2 years
次要结局
- maximum tolerated dose(2 years)
- antibody and T-cell response(2 years)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
1 期
Vaccine Therapy in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV MelanomaIntraocular MelanomaMelanoma (Skin)NCT00398073Memorial Sloan Kettering Cancer Center35
已完成
2 期
Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Metastatic MelanomaStage IV MelanomaRecurrent MelanomaNCT00019448National Cancer Institute (NCI)
Unknown
2 期
Vaccine Therapy and Celecoxib in Treating Patients With Metastatic Nasopharyngeal CancerHead and Neck CancerNCT00589186National Cancer Centre, Singapore35
已完成
1 期
Vaccine Therapy With Sargramostim (GM-CSF) in Treating Patients With Her-2 Positive Stage III-IV Breast Cancer or Ovarian CancerHER2-positive Breast CancerStage III Ovarian Epithelial CancerStage III Ovarian Germ Cell TumorStage IIIA Breast CancerStage IIIB Breast CancerStage IIIC Breast CancerStage IV Breast CancerStage IV Ovarian Epithelial CancerStage IV Ovarian Germ Cell TumorNCT00436254University of Washington66
终止
2 期
Phase II Study of Allo LMI Vaccine With IL-2 for Stable Metastatic Breast CaBreast CancerNCT00784524Masonic Cancer Center, University of Minnesota14
